Multiple Company Financial Results and Regulatory Disclosures

Ovobel Foods Limited Compliance Notice

Ovobel Foods Limited published newspaper notices pursuant to SEBI Circular SEBI/HO/38/13/11(2) 2026-MIRSD-POD/1/370/2026 dated 30th January, 2026. The notices were published in Financial Express (English) on 22 May 2026 and Hosadigantha (Kannada) on 23 May 2026. The notice was signed by SHARAD M S, Managing Director (DIN: 08987445) from Bengaluru.

EPACK Durable Limited Financial Results

The Board of Directors approved Standalone and Consolidated Audited Financial Results for quarter and year ended March 31, 2026 at their meeting held on May 20, 2026. The results were audited by Deloitte Haskin and Sells and are available on company website and stock exchange websites. The disclosure was signed by Ajay DD Singhania, Managing Director and CEO.

DSP Finance Private Limited Financial Results

The Board of Directors approved audited financial results for quarter and year ended March 31, 2026 at their meeting held on May 21, 2026. Results are available on BSE website and company website. Signed by Jayesh Jayantilal Mehta, Whole-Time Director & CEO (DIN: 00030636).

Quintessence Enterprises Merchant Banker Registration Surrender

Public notice regarding voluntary surrender of SEBI Merchant Banker registration (Certificate No: INM00001197, effective from 01/08/2012). The company is applying to SEBI for surrender and has invited grievances from clients/investors to be submitted within 30 days via scores.gov.in or email at info@geplindia.com and quintessence@geplindia.com.

Special Window for Physical Share Transfer Notice

Multiple companies (Ovobel Foods Limited, Maharashtra Scooters Limited) announced special window for transfer and dematerialization of physical shares pursuant to SEBI circular no. HO/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated January 30, 2026.

Window Period: February 05, 2026 to February 04, 2027 (one year)

Eligibility: Transfer and dematerialization of physical shares sold or purchased prior to April 01, 2019, including previously rejected/returned requests due to documentation deficiencies.

Conditions:

  • Securities will be credited only in demat mode
  • Lock-in period of one year from date of registration of transfer
  • During lock-in, securities cannot be transferred/pledged/lienmarked

Exclusions: Disputes between transferor & transferee; Securities transferred to IEPF

Contact Details provided for Ovobel Foods: RTA - Maheshwari Datamatics Private Limited, Kolkata; Company - Bengaluru office

Contact Details for Maharashtra Scooters: RTA toll free - 1800-309-4001; email - einward.ris@kfintech.com

Voith Paper Fabrics India Limited Financial Results

Financial Performance (Standalone, INR in Million)

Quarter Ended 31/03/2026:

  • Total Income from Operations: ₹582.38 (vs ₹563.96 in Q4 FY25)
  • Profit before exceptional item and tax: ₹134.47 (vs ₹152.74 in Q4 FY25)
  • Exceptional item: ₹14.54
  • Net profit after tax: ₹91.53 (vs ₹113.41 in Q4 FY25)
  • Total Comprehensive Income: ₹94.43
  • Basic EPS: ₹20.84 (vs ₹25.83 in Q4 FY25)

Full Year Ended 31/03/2026:

  • Total Income from Operations: ₹2,280.94 (vs ₹2,066.23 in FY25)
  • Profit before exceptional item and tax: ₹603.35 (vs ₹537.26 in FY25)
  • Exceptional item: ₹50.97
  • Net profit after tax: ₹414.49 (vs ₹398.93 in FY25)
  • Total Comprehensive Income: ₹434.26
  • Basic EPS: ₹94.36 (vs ₹90.87 in FY25)
  • Equity Share Capital: ₹43.93 (unchanged)
  • Reserves: ₹4,193.13 (vs ₹3,802.80 in FY25)

Exceptional Items Note: Additional gratuity provision of ₹14.54 million recorded in Q4 FY26 due to impact assessment of new labour codes notified on November 21, 2025. This follows ₹36.43 million provision in Q3 FY25.

Dividend: Board recommended final dividend of 100% (₹10 per equity share of ₹10 each) for FY26, subject to shareholder approval.

Audit: Financial results prepared under Ind-AS, audited by Statutory Auditors with unmodified audit report.

Dr. Agarwal's Health Care Limited Financial Results

Board approved Audited Financial Results (Standalone and Consolidated) for quarter and year ended March 31, 2026 at meeting held on May 21, 2026. Results available on company website and stock exchanges. Signed by Dr. Adil Agarwal, Whole-Time Director & CEO (DIN: 01074272).

Windlas Biotech Limited Financial Results

Financial Performance (₹ in millions, except per share data)

Standalone Q4 FY26:

  • Revenue from Operations: ₹2,384.99 (vs ₹2,027.05 in Q4 FY25)
  • Net Profit before tax: ₹201.62 (vs ₹208.27 in Q4 FY25)
  • Net Profit after tax: ₹160.16 (vs ₹162.85 in Q4 FY25)
  • Total Comprehensive Income: ₹160.93
  • Basic EPS: ₹7.60 (vs ₹7.77 in Q4 FY25)
  • Diluted EPS: ₹7.50 (vs ₹7.69 in Q4 FY25)

Standalone Full Year FY26:

  • Revenue from Operations: ₹9,040.89 (vs ₹7,598.78 in FY25)
  • Net Profit before tax: ₹869.31 (vs ₹793.94 in FY25)
  • Net Profit after tax: ₹664.35 (vs ₹606.49 in FY25)
  • Total Comprehensive Income: ₹665.46
  • Basic EPS: ₹31.59 (vs ₹29.03 in FY25)
  • Diluted EPS: ₹31.14 (vs ₹28.71 in FY25)
  • Equity Share Capital: ₹105.53 (vs ₹104.80 in FY25)
  • Reserves: ₹5,702.80 (vs ₹4,953.08 in FY25)

Consolidated results show similar performance trends. Results reviewed by audit committee and approved by board on May 21, 2026.